ACV AUCTIONS INC.

ACVA

CIK 0001637873 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$184M
↑+15.1% +$24Mvs FY2024 (Q4)
Operating Income
$122M
↑+32.1% +$30Mvs FY2024 (Q4)
Net Income
$119M
↑+31.6% +$28Mvs FY2024 (Q4)
Gross Profit
$184M
↑+15.1% +$24Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
59/100
  • Profitability
    0ROIC -11.5% (10% = solid, 20%+ = moat)
  • Liquidity
    55Current Ratio 1.60 (above 1.5 = solid)
  • Leverage
    92D/E 0.16 (under 0.5 = conservative)
  • Efficiency
    41Asset Turnover 0.73x (1.0+ = capital-efficient)
  • Growth
    67Revenue YoY +15.1% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -11.9% · trend +4.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ACVA's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$6.97
Total enterprise IV
$1.19B
Diluted shares
0.17B
Terminal PV
$862M (72% of total)
Year-5 FCF
$102M
YearProjected FCFDiscounted PV
+1$75M$68M
+2$81M$67M
+3$87M$65M
+4$94M$64M
+5$102M$63M
Terminal$1.39B$862M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$9M
investment in PP&E
Stock-based comp (TTM)
$57M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.09B
everything owned
Total liabilities
$656M
everything owed
Stockholders' equity
$430M
shareholder claim
Net debt
$-176M
Net cash position ($176M)

Recent performance · 25 quarters

Revenue↑+15.1% +$24M
$184M
Net Income↓-52.6% -$8M
$-24M
Free Cash Flow↓-225.0% -$2M
$-2M
Operating Margin↓-1.9pts
-11.9%

Drill down